Business
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street
Twelve months of national and global coverage to include long-form interviews, earned media, television commercials, iconic outdoor billboards, and accredited investor events NEW YORK CITY, NEW YORK / ACCESS Newswire / February 5, 2026 / Vivos Therapeutics, ...
About this update from Vivos Therapeutics, Inc.
[{"type":"text","content":"Twelve months of national and global coverage to include long-form interviews, earned media, television commercials, iconic outdoor billboards, and accredited investor events","length":174,"tagName":"p"},{"type":"text","content":"NEW YORK CITY, NEW YORK / ACCESS Newswire / February 5, 2026 / Vivos Therapeutics, Inc. (NASDAQ:VVOS), a medical technology company focused on innovative solutions for breathing and sleep disorders, today announced that it has entered into a 12-part media series agreement with New to The Street, one of the longest-running business television and digital media platforms serving public companies in the U.S. and international markets.","length":435,"tagName":"p"},{"type":"text","content":"The 12-month series is designed to expand Vivos Therapeutics' visibility among investors, healthcare professionals, and strategic partners through a comprehensive, multi-channel media strategy spanning linear television, digital platforms, social media, outdoor advertising, and live investor engagement.","length":308,"tagName":"p"},{"type":"text","content":"As part of the agreement, Vivos Therapeutics will receive:","length":58,"tagName":"p"},{"type":"text","content":"Long-form broadcast interviews distributed nationally and internationally","length":73,"tagName":"p"},{"type":"text","content":"Earned media coverage supporting corporate milestones and clinical positioning","length":78,"tagName":"p"},{"type":"text","content":"Television commercials airing as sponsored programming alongside New to The Street broadcasts","length":93,"tagName":"p"},{"type":"text","content":"Iconic outdoor billboard placements in high-impact financial and metropolitan locations","length":87,"tagName":"p"},{"type":"text","content":"Accredited investor events, providing direct engagement with screened, invitation-only investor audiences","length":105,"tagName":"p"},{"type":"text","content":"The series will allow Vivos Therapeutics to consistently communicate its clinical progress, commercial execution, and long-term growth strategy throughout the year.","length":164,"tagName":"p"},{"type":"text","content":""Partnering with New to The Street provides a sustained, credible platform to communicate our story to a broad audience of investors and stakeholders," said a spokesperson for Vivos Therapeutics. "This multi-part series suppo...